X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
cirrosi hepàtica (83) 83
hepatic cirrhosis (72) 72
humans (40) 40
index medicus (34) 34
male (30) 30
liver cirrhosis (29) 29
liver diseases (29) 29
cirrhosis (25) 25
gastroenterology & hepatology (25) 25
female (22) 22
liver (22) 22
middle aged (22) 22
prognosis (22) 22
malalties del fetge (21) 21
liver cirrhosis - complications (18) 18
hipertensió portal (16) 16
adult (15) 15
portal hypertension (15) 15
aged (14) 14
ciències de la salut (14) 14
research article (13) 13
mortality (12) 12
care and treatment (11) 11
gastroenterology and hepatology (11) 11
hepatitis (11) 11
multidisciplinary sciences (11) 11
rodents (11) 11
hypertension (10) 10
pronòstic mèdic (10) 10
research (10) 10
animals (9) 9
diagnosis (9) 9
inflammation (9) 9
liver cirrhosis - physiopathology (9) 9
liver failure (9) 9
medicine (9) 9
patients (9) 9
rats (9) 9
studies (9) 9
616 - patologia. medicina clínica. oncologia (8) 8
biochemical markers (8) 8
hepatology (8) 8
infections (8) 8
inflamació (8) 8
liver cirrhosis - blood (8) 8
proteins (8) 8
science (8) 8
abridged index medicus (7) 7
article (7) 7
ascites (7) 7
biomarkers (7) 7
insuficiència hepàtica (7) 7
marcadors bioquímics (7) 7
portal-hypertension (7) 7
analysis (6) 6
assaigs clínics (6) 6
chronic liver-failure (6) 6
clinical trials (6) 6
disease (6) 6
fibrosis (6) 6
gastroenterology (6) 6
hemorrhage (6) 6
hepatitis c (6) 6
liver cirrhosis - mortality (6) 6
nitric oxide (6) 6
severity of illness index (6) 6
acute kidney injury (5) 5
bacterial infections (5) 5
biomarkers - blood (5) 5
cirrosi (5) 5
development and progression (5) 5
hepatic transplantation (5) 5
immunology (5) 5
liver - pathology (5) 5
liver cirrhosis - diagnosis (5) 5
liver cirrhosis - drug therapy (5) 5
risk factors (5) 5
spontaneous bacterial peritonitis (5) 5
survival (5) 5
therapy (5) 5
transplantation (5) 5
trasplantament hepàtic (5) 5
treatment outcome (5) 5
biochemistry (4) 4
biology and life sciences (4) 4
biomarker (4) 4
biopsy (4) 4
chronic hepatitis-c (4) 4
complications (4) 4
esophageal-varices (4) 4
fetge (4) 4
gene expression (4) 4
genotype & phenotype (4) 4
health aspects (4) 4
hemodynamics (4) 4
hepatic encephalopathy (4) 4
hepatitis c virus (4) 4
hepatorenal-syndrome (4) 4
hypertension, portal - complications (4) 4
hypertension, portal - physiopathology (4) 4
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


ISSN 0270-9139, 11/2018
Decompensated cirrhosis is characterized by exuberant systemic inflammation. Although the inducers of this feature remain unknown, the presence of circulating... 
Cirrosi hepàtica | Leucòcits | Leucocytes | Hepatic cirrhosis | Inflamació | Inflammation
Journal Article
ISSN 0016-5085, 02/2011
BACKGROUND & AIMS: The prognostic value of the different causes of renal failure in cirrhosis is not well established. This study investigated the predictive... 
Cirrosi hepàtica | Hepatic cirrhosis
Journal Article
by Clària, Joan and Stauber, Rudolf E and Coenraad, Minneke J and Moreau, Richard and Jalan, Rajiv and Pavesi, Marco and Amorós, Àlex and Titos, Esther and Alcaraz‐Quiles, José and Oettl, Karl and Morales‐Ruiz, Manuel and Angeli, Paolo and Domenicali, Marco and Alessandria, Carlo and Gerbes, Alexander and Wendon, Julia and Nevens, Frederik and Trebicka, Jonel and Laleman, Wim and Saliba, Faouzi and Welzel, Tania M and Albillos, Agustin and Gustot, Thierry and Benten, Daniel and Durand, François and Ginès, Pere and Bernardi, Mauro and Arroyo, Vicente and Melero, Patricia Aguilar and Bañares, Rafael and Bocci, Massimo and Caraceni, Paolo and Catalina, María‐Vega and Chin, Jun Liong and Concepción, Mar and Coilly, Audrey and Deulofeu, Carme and Elkrief, Laure and Fernandez, Javier and Gola, Elisabetta and de Gottardi, Andrea and Grøenbæk, Henning and Hausen, AnneKristin and Lohse, Ansgar W and Maggioli, Caterina and Markwardt, Daniel and Martinez, Javier and de la Mata, Manuel and McCormick, P. Aiden and Mesonero, Francisco and Álvarez, José Luis Montero and Mookerjee, Rajeshwar P and Moreno, Christophe and Morrell, Bernhard and Mortensen, Christian and Peck‐Radosavljevic, Markus and Risso, Alessandro and Samuel, Didier and Simon‐Talero, Macarena and Solà, Elsa and Solis‐Muñoz, Pablo and Soriano, German and Sperl, Jan and Spindelboeck, Walter and Valla, Dominique and Vargas, Victor and Van Vlierberghe, Hans and Vogel, Wolfgang and Wege, Henninge and Willars, Chris and Zaccherini, Giacomo and Zeuzem, Stefan and EASL-CLIF Consortium and European Fdn Study CHRONIC Liver
Hepatology, ISSN 0270-9139, 10/2016, Volume 64, Issue 4, pp. 1249 - 1264
Acute‐on‐chronic liver failure (ACLF) in cirrhosis is characterized by acute decompensation (AD), organ failure(s), and high short‐term mortality. Recently, we... 
IMMUNE | ACUTE KIDNEY INJURY | REDOX STATE | HUMAN SERUM-ALBUMIN | DISEASE | HEMODIALYSIS-PATIENTS | EMERGENCY HEMATOPOIESIS | CYTOKINE | SEPTIC KIDNEY | SEPSIS | GASTROENTEROLOGY & HEPATOLOGY | Hypotheses | Cytokines | Alcoholism | Rodents | Cirrosi hepàtica | Malalties del fetge | Inflammation | Liver diseases | Hepatic cirrhosis | Inflamació
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2014, Volume 370, Issue 21, pp. 1973 - 1982
In patients with HCV genotype 1 infection and cirrhosis, the rate of sustained virologic response was 92% with three new antiviral agents plus ribavirin for 12... 
SUSTAINED VIROLOGICAL RESPONSE | ALL-CAUSE MORTALITY | UNITED-STATES | MEDICINE, GENERAL & INTERNAL | VIRUS-INFECTION | TELAPREVIR | THERAPY | GENOTYPE 1 INFECTION | BOCEPREVIR | HCV INFECTION | EPIDEMIOLOGY | Recurrence | Anilides - therapeutic use | Anilides - adverse effects | Humans | Middle Aged | Drug Resistance, Viral | Hepacivirus - genetics | Male | Hepatitis C, Chronic - complications | Adult | Female | Drug Therapy, Combination | Hepacivirus - isolation & purification | Liver Cirrhosis - drug therapy | Liver Cirrhosis - etiology | Antiviral Agents - therapeutic use | Ribavirin - therapeutic use | Genotype | Logistic Models | Macrocyclic Compounds - adverse effects | Hepatitis C, Chronic - drug therapy | Macrocyclic Compounds - therapeutic use | Ribavirin - adverse effects | Antiviral Agents - adverse effects | Carbamates - adverse effects | Aged | Carbamates - therapeutic use | Complications and side effects | Evaluation | Care and treatment | Usage | Hepatitis C | Liver cirrhosis | Ribavirin | Headache | Antiviral agents | Ritonavir | Body weight | Fatigue | Infections | Nausea | Proteinase inhibitors | RNA polymerase | Patients | Cirrhosis | Liver cancer | Genotype & phenotype | Hepatitis | Hemoglobin | Interferon | Drug therapy | Genotypes | Index Medicus | Abridged Index Medicus | Cirrosi hepàtica | Inhibidors enzimàtics | Enzyme inhibitors | Hepatic cirrhosis
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2010, Volume 362, Issue 25, pp. 2370 - 2379
Journal Article
Gastroenterology, ISSN 0016-5085, 2013, Volume 144, Issue 1, pp. 102 - 111.e1
Journal Article